CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: Sanofi, Regeneron expand partnership after Dupixent success

PartnershipDupixentPositive
AI Analysis

Summary

Sanofi and Regeneron have expanded their partnership to build on the blockbuster success of Dupixent. The collaboration re-up demonstrates confidence in the drug's continued commercial performance.

Importance:6/10
Sentiment:
0.70
partnership expansioncollaborationDupixentcommercial success
Related Companies

Read the original article

Published by STAT News on October 1, 2026 6:16 AM

Read Original